(Q44719681)

5 December 2017

title

Imatinib sensitizes CLL lymphocytes to chlorambucil (English)

1 reference

5 December 2017

1 reference

Aloyz R

1

1 reference

5 December 2017

Grzywacz K

2

1 reference

5 December 2017

Xu ZY

3

1 reference

5 December 2017

Loignon M

4

1 reference

5 December 2017

Alaoui-Jamali MA

5

1 reference

5 December 2017

Panasci L

6

1 reference

5 December 2017

publication date

1 March 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

18

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

409-414

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403247

5 December 2017

exact match

0 references

cites work

Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

High levels of chromosome aberrations correlate with impaired in vitro radiation-induced apoptosis and DNA repair in human B-chronic lymphocytic leukaemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Regulation of Rad51 function by c-Abl in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Regulation of cell death by the Abl tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Cytostatic synergism between bromodeoxyuridine, bleomycin, cisplatin and chlorambucil demonstrated by a sensitive cell kinetic assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: a translational perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

Synergistic actions of Rad51 and Rad52 in recombination and DNA repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403247

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403247

1 reference

Dimensions Publication ID

5 December 2017

1038133377

0 references

1 reference